As former Head of Innovation Management and Scouting and member of Takeda’s Digital Strategy team Ronald helped Takeda with its technology and innovation strategy. Earlier, at the Life Science division of PA Consulting, Ronald led projects for some of the world’s top 10 pharmaceutical companies around strategy, commercialization and digital health. As founder of BioFrontline he provides management, strategy and commercial advice to life sciences companies in the US, Europe and Asia. After obtaining MAs in Biotechnology and Molecular Biology and a PhD in Pharmaceutical Biology in the Netherlands Ronald led research projects on Parkinson’s disease, Schizophrenia and the genetics of aggressive behavior, before making the transition to industry. As a consultant Ronald got involved in projects related to artificial intelligence and he has been following that field for over 10 years. He is frequently invited to deliver presentations and keynotes related to AI in Pharma and Healthcare and has presented at national and international events. Ronald founded the LinkedIn groups ‘AI – Artificial Intelligence’, ‘Small Molecules’, ‘Boston Biotech’ and ‘Golden Triangle Biotech’ that serve over 10,000 members.